Design of Three Residues Peptides against SARS-CoV-2 Infection
Design of Three Residues Peptides against SARS-CoV-2 Infection
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
The continuous and rapid spread of the COVID-19 pandemic has emphasized the need to seek new therapeutic and prophylactic treatments. Peptide inhibitors are a valid alternative approach for the treatment of emerging viral infections, mainly due to their low toxicity and high efficiency. Recently, two small nucleotide signatures were identified in t...
Alternative Titles
Full title
Design of Three Residues Peptides against SARS-CoV-2 Infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7fd10384bef647fa808f8b46d5cc4735
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7fd10384bef647fa808f8b46d5cc4735
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v14102103
